רספרים

Land: Israel

Språk: hebraisk

Kilde: Ministry of Health

Aktiv ingrediens:

SULPHAMETHOXAZOLE; TRIMETHOPRIM

Tilgjengelig fra:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

ATC-kode:

J01EE01

Legemiddelform:

תרחיף

Sammensetning:

SULPHAMETHOXAZOLE 200 MG / 5 ML; TRIMETHOPRIM 40 MG / 5 ML

Administreringsrute:

פומי

Resept typen:

מרשם נדרש

Produsert av:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Terapeutisk gruppe:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Terapeutisk område:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Indikasjoner:

Treatment of urinary tract infections due to susceptible strains of the following organisms: - Escherichia coli - Klebsiella - Enterobacter - Proteus mirabilis - Proteus vulgaris - Proteus morganii. Treatment of acute otitis media in children due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. To date there are limited data available as to the safety of repeated use of Resprim in infants under 2 years of age. Resprim is not indicated for prophylactic or prolonged administration in otitis media at any age. Treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. Treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei. Resprim is also indicated in the treatment of documented Pneumocystis carinii pneumonitis.

Autorisasjon dato:

2012-01-31